Possible scenario
Price Pressure Intensifies
24% Chance
Rapid adoption makes GLP-1s a large and visible budget item for Medicare, Medicaid, employers, and commercial insurers. Policymakers accept the health benefits but push harder on rebates, negotiated prices, and step-therapy rules.
Secondary impacts
- Healthcare -0.9%
- Consumer Non-Cyclicals -0.1%
Tickers
- LLY-1.9%
- HUM+0.7%
- CVS+0.5%
- CI+0.5%
- +0.5%
Portfolio impact
S&P 500-0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.